Picture of Kanabo logo

KNB Kanabo News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

REG - Kanabo Group PLC - Appointment of Ian Mattioli as Non-Executive Chair

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20230509:nRSI6715Ya&default-theme=true

RNS Number : 6715Y  Kanabo Group PLC  09 May 2023

9 May 2023

 

Kanabo Group plc

("Kanabo", the "Group" or the "Company")

 

Appointment of Ian Mattioli MBE as Non-Executive Chair of the Board

 

Kanabo Group plc (LSE: KNB), (https://www.team17groupplc.com/) the patient
focused healthcare technology and medicinal cannabis company, announces the
appointment of Ian Mattioli MBE as Non-Executive Chair with immediate effect.

 

Ian Mattioli, co-founder and CEO of a leading UK pensions and wealth
management consultancy, brings extensive experience in financial services,
wealth management and capital markets.

 

Key Highlights:

·    Co-founder and CEO of Mattioli Woods PLC, a leading UK pensions and
wealth management consultancy.

·    Ian created and founded the property business Custodian Property
Income REIT plc which listed on the London Stock Exchange Main Market in 2014.

·    Recipient of London Stock Exchange AIM Entrepreneur of the Year and
CEO of the Year in the 2018 City of London Wealth Management Awards.

Mr David Tsur, who has served as the Kanabo's Non-Executive Chair since the
Company's admission to the London Stock Exchange in February 2021, will
transition to Deputy Chair following Ian Mattioli's appointment.

 

David Tsur, Deputy Chair of Kanabo:

"We are delighted to welcome Ian to the leadership team as we embark on a year
of growth and expansion into new markets and services. His experience and
understanding of London's capital markets will be invaluable as we work to
advance our strategic goals for the company. Since the Company's admission to
the London Stock Exchange, we have achieved numerous significant milestones,
including launching two medical cannabis products, building a comprehensive
supply chain, acquiring The GP Service, and launching Treat-It, our innovative
digital health platform for pain management."

 

Ian Mattioli MBE, added:

"I am delighted to join Kanabo as a Chair and am impressed with the Company's
commitment to personalised, accessible, and affordable healthcare. With its
leading-edge technology and disruptive products, Kanabo is poised for
significant growth in the digital health sector. I am keen to contribute my
experience and knowledge to support Kanabo in its future success."

 

Additional information about Ian Mattioli MBE

Ian Mattioli brings considerable financial services, wealth management,
property and capital markets experience to the Group. Ian Mattioli co-founded
the wealth management group, Mattioli Woods PLC ("Mattioli Woods"), in 1991
and has held the role of CEO since Mattioli Woods was admitted to AIM in 2005.
He is responsible for the vision and operational management of the Group.
Mattioli Woods is one of the UK's leading consultancies in the provision of
pensions and wealth management services for controlling directors,
professional persons, owner-managed businesses, and small-to-medium-sized
PLCs.

 

Ian Mattioli has received many accolades for his business acumen, including
being awarded the London Stock Exchange AIM Entrepreneur of the Year award and
CEO of the Year in the 2018 City of London Wealth Management Awards. Ian
Mattioli was awarded an MBE for services to business and the community in
Leicestershire in the Queen's 2017 Honours List. In 2022, the University of
Leicester awarded Ian Mattioli an honorary degree (Doctor of Laws).

 

Ian Mattioli is currently Chief Executive Officer of Mattioli Woods Plc, and
Non-Executive Director of Custodian Property Income REIT Plc.

 

Save for the information disclosed below, Kanabo confirms there is no further
information to be disclosed under the requirements of Listing Rule 9.6.13 in
relation to the appointment of Ian Mattioli as Non-Executive Director.

 

 Current Directorships                            Non-current directorships (past 5 years)
 Mattioli Woods Plc                               K3 Capital Group Plc
 Custodian Property Income REIT Plc               DRUM Income Plus REIT plc

 

Ian Mattioli currently holds 500,000 ordinary shares in the Company,
representing 0.1% of the issued share capital.

 

Enquiries:

 

 Kanabo Group plc                                                  via Vigo Consulting

 Avihu Tamir, Chief Executive Officer                              +44 (0)20 7390 0230

 Assaf Vardimon, Chief Financial Officer

 Ian Mattioli,  Non-Executive Chair of the Board

 Peterhouse Capital Ltd (Financial Adviser and Broker)             +44 (0)20 7469 0930

 Eran Zucker / Lucy Williams / Charles Goodfellow

 Vigo Consulting (Financial Public Relations/Investor Relations)    +44 (0)20 7390 0230

 Jeremy Garcia / Fiona Hetherington / Verity Snow

 kanabo@vigoconsulting.com

 

About Kanabo Group Plc

Kanabo Group Plc (LSE:KNB) is a healthtech company committed to
revolutionising patient care through its innovative technology platform and
disruptive product offerings. Since its inception in 2017, Kanabo has been
focused on researching, developing, and commercialising regulated medicinal
cannabis-derived formulations and therapeutic inhalation devices.

 

Kanabo's NHS-approved online telehealth platform, The GP Service, provides
patients with video consultations, online prescriptions, and primary care
services. The Company is a leader in its field, focusing on improving patient
outcomes and providing more accessible healthcare experiences.

 

In March 2023, Kanabo successfully launched its Pain Clinic, Treat It, under
the expert guidance of its technological and product expertise. Treat It
initially focuses on chronic pain management using plant-based medicine and
treatments that are currently unavailable through traditional channels.

 

At Kanabo Group Plc, we are dedicated to providing patients with the highest
quality medical treatments and more accessible healthcare experiences.

Visit www.kanabogroup.com (http://www.kanabogroup.com) for more information.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  BOABIGDUIDGDGXI

Recent news on Kanabo

See all news